These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 1581984)

  • 1. [Fundamentals in making projections for new drugs].
    Remko M
    Cesk Farm; 1992 Feb; 40(8-10):244-8. PubMed ID: 1581984
    [No Abstract]   [Full Text] [Related]  

  • 2. [Identity tests of chemical drugs in CsL 3].
    Zahradnícek M
    Cesk Farm; 1971 Mar; 20(2):63-74. PubMed ID: 5550005
    [No Abstract]   [Full Text] [Related]  

  • 3. Molecular cross-fertilization.
    Nat Chem Biol; 2006 Feb; 2(2):53. PubMed ID: 16421578
    [No Abstract]   [Full Text] [Related]  

  • 4. [Molecular galenical evaluation of the conventional handling of solids in homeopathy].
    Hüttenrauch R; Fricke S
    Pharmazie; 1985 Feb; 40(2):129-30. PubMed ID: 4001150
    [No Abstract]   [Full Text] [Related]  

  • 5. Development of quality control methodology for new drugs.
    Wagner RL
    Bull Parenter Drug Assoc; 1972; 26(2):76-86. PubMed ID: 5012206
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of chemical structure on the biological activity of pharmaceutical drugs].
    Machoń Z
    Postepy Hig Med Dosw; 1972; 26(6):773-91. PubMed ID: 4671371
    [No Abstract]   [Full Text] [Related]  

  • 7. [Studies on the chemistry of drugs. Panegyric or funeral oration?].
    Lespagnol A; Lespagnol C
    Actual Pharmacol (Paris); 1977; 29():155-77. PubMed ID: 868616
    [No Abstract]   [Full Text] [Related]  

  • 8. [Electrical dipolar momentum and molecular structure, with observations on their relation to pharmaceutical chemistry].
    KOFOD H
    Dan Tidsskr Farm; 1951 Sep; 25(9):298-318. PubMed ID: 14879533
    [No Abstract]   [Full Text] [Related]  

  • 9. [Polymorphy of drugs. II].
    Hoeke M
    Pharm Weekbl; 1969 Oct; 104(44):1386. PubMed ID: 5352089
    [No Abstract]   [Full Text] [Related]  

  • 10. [Controlled-release drugs: administration routes and formulations].
    Nicoli S; Colombo P
    Ann Pharm Fr; 2001 Jul; 59(4):227-31. PubMed ID: 11468576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Use of gas chromatography and mass spectrometry in forensic chemistry for the demonstration of drugs and their metabolites].
    Chundela B; Slechtová R
    Beitr Gerichtl Med; 1974; 32():206-14. PubMed ID: 4468785
    [No Abstract]   [Full Text] [Related]  

  • 12. [Metal complexes and the action of drugs].
    Doornbos DA
    Pharm Weekbl; 1966 Mar; 101(12):273-85. PubMed ID: 5934969
    [No Abstract]   [Full Text] [Related]  

  • 13. [Constitution and effect of biologically active compounds. 17. Common structural principals in drugs].
    Perkow W
    Arzneimittelforschung; 1966 Oct; 16(10):1287-97. PubMed ID: 6014910
    [No Abstract]   [Full Text] [Related]  

  • 14. Microcrystalline identification of drugs of abuse: stimulant street drugs.
    Julian EA; Plein EM
    J Forensic Sci; 1983 Oct; 28(4):992-9. PubMed ID: 6138389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New opportunities for biocatalysis: making pharmaceutical processes greener.
    Woodley JM
    Trends Biotechnol; 2008 Jun; 26(6):321-7. PubMed ID: 18436317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Chemical changes of drugs with a view to improvement of their action].
    Wermuth CG
    Agressologie; 1966; 7(3):213-9. PubMed ID: 5937297
    [No Abstract]   [Full Text] [Related]  

  • 17. [New analytical orientations in the study of drugs].
    Frigerio A; Marchioro C; Pastorino A
    Boll Chim Farm; 1986 May; 125(5):138-43. PubMed ID: 3801158
    [No Abstract]   [Full Text] [Related]  

  • 18. Comments on the empirical and the rational method for the development of new drugs. An introduction to medicinal chemistry.
    Lund-Jensen C
    Pharm Acta Helv; 1967 Apr; 42(4):193-208. PubMed ID: 5582514
    [No Abstract]   [Full Text] [Related]  

  • 19. [The relationship between structure and on plate-oxidation susceptibility of drugs with a 3,5-pyrazolidinedione group].
    Takács M; Kertész P; Reisch J
    Pharm Acta Helv; 1986; 61(5-6):148-9. PubMed ID: 3725814
    [No Abstract]   [Full Text] [Related]  

  • 20. Researching new drugs.
    Iowa Med; 1988 May; 78(5):230-3. PubMed ID: 3391751
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.